TherapeuticsMD, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q3 2011 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
TherapeuticsMD, Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from Q3 2011 to Q3 2022.
  • TherapeuticsMD, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2022 was -$260K.
Income Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$260K -$260K Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $550K +$550K Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q3 2021 $0 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $0 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $0 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $0 Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q3 2011 $4.3K Jul 1, 2011 Sep 30, 2011 10-Q 2011-11-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.